These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 33968794)

  • 1. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease.
    Huang Y; Liao J; Liu X; Zhong Y; Cai X; Long L
    Front Cell Infect Microbiol; 2021; 11():615075. PubMed ID: 33968794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease.
    Baizabal-Carvallo JF; Alonso-Juarez M
    Neuroscience; 2020 Apr; 432():160-173. PubMed ID: 32112917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and intestinal dysbiosis in Parkinson's disease.
    Berthouzoz E; Lazarevic V; Zekeridou A; Castro M; Debove I; Aybek S; Schrenzel J; Burkhard PR; Fleury V
    Rev Neurol (Paris); 2023 Nov; 179(9):937-946. PubMed ID: 36934020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the Gut Microbiome in Parkinson's Disease.
    Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
    Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gut microbiota and Parkinson's disease.
    Pant A; Bisht KS; Aggarwal S; Maiti TK
    Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease.
    Fang X; Liu S; Muhammad B; Zheng M; Ge X; Xu Y; Kan S; Zhang Y; Yu Y; Zheng K; Geng D; Liu CF
    Neural Regen Res; 2024 Sep; 19(9):2081-2088. PubMed ID: 38227539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
    Rani L; Mondal AC
    Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease.
    Cirstea MS; Yu AC; Golz E; Sundvick K; Kliger D; Radisavljevic N; Foulger LH; Mackenzie M; Huan T; Finlay BB; Appel-Cresswell S
    Mov Disord; 2020 Jul; 35(7):1208-1217. PubMed ID: 32357258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of The Gut Microbiome in Parkinson's Disease.
    Gallop A; Weagley J; Paracha SU; Grossberg G
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):253-262. PubMed ID: 34219519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
    Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
    Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.
    van IJzendoorn SCD; Derkinderen P
    J Parkinsons Dis; 2019; 9(s2):S323-S329. PubMed ID: 31561386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease and the gastrointestinal microbiome.
    Lubomski M; Tan AH; Lim SY; Holmes AJ; Davis RL; Sue CM
    J Neurol; 2020 Sep; 267(9):2507-2523. PubMed ID: 31041582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
    Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
    Front Immunol; 2022; 13():937555. PubMed ID: 35812394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.